Nebulized Hypertonic Saline for Inpatient Use in COPD

Completed · Phase 4

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

A comparison of albuterol treatments using hypertonic saline (3%) versus standard saline (0.9%) in patients with admitted patients COPD in regard to Modified Borg Dyspnea scale scores after 4 treatments within 24 hours.

Key facts

Study ID

NCT02266875

Run by

OhioHealth

People needed

70

Starts

2014-10-01

Expected to finish

2017-01-30

Last updated by the study team

2017-11-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients at least 18 years of age
• Admitted to Doctors Hospital with a clinical diagnosis of COPD
• Documented obstruction on spirometry from prior records available at the time of the study.

You may not qualify if…

• Patients younger than 18 years of age
• Spirometry data not available
• History of smoking less than twenty pack-years
• Possibility of other primary cause of the patient's change in dyspnea or cough (e.g. pneumonia, congestive heart failure with pulmonary edema, myocardial infarction)
• Patient is found to have a different primary cause after initial enrollment
• Non-English speaking subjects

Where it is running

• Doctors Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.